Page last updated: 2024-08-22

fluorescein-5-isothiocyanate and Graft vs Host Disease

fluorescein-5-isothiocyanate has been researched along with Graft vs Host Disease in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biondi, A; Bonamino, M; Borleri, G; Golay, J; Imberti, L; Introna, M; Manganini, M; Rambaldi, A; Serafini, M1
Choi, WS; Kim, HJ; Kim, J; Kwon, B1
Aghaiipour, M; Bernard, D; David, G; Hadjati, E; Iravani, M; Shaiegan, M1
Abhyankar, S; Bhan, AK; Burakoff, SJ; Ferrara, JL; Golan, DE; Jones, WK; Michaelson, J; Sakamoto, H; Silverstein, M1

Other Studies

4 other study(ies) available for fluorescein-5-isothiocyanate and Graft vs Host Disease

ArticleYear
Characterization of CD20-transduced T lymphocytes as an alternative suicide gene therapy approach for the treatment of graft-versus-host disease.
    Human gene therapy, 2004, Volume: 15, Issue:1

    Topics: Antigens, CD20; Complement System Proteins; Fluorescein-5-isothiocyanate; Genes, Transgenic, Suicide; Genetic Therapy; Graft vs Host Disease; Humans; Phenotype; T-Lymphocytes; Transduction, Genetic

2004
Prevention of chronic graft-versus-host disease by stimulation with glucocorticoid-induced TNF receptor.
    Experimental & molecular medicine, 2006, Feb-28, Volume: 38, Issue:1

    Topics: Animals; Antibodies, Monoclonal; B-Lymphocytes; CD4-Positive T-Lymphocytes; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique, Indirect; Fluorescent Dyes; Glucocorticoids; Graft vs Host Disease; Mice; Mice, Inbred DBA; Mice, Inbred Strains; Microscopy, Confocal; Receptors, Tumor Necrosis Factor; Transplantation, Homologous

2006
Flow cytometric evaluation of red blood cell chimerism after bone marrow transplantation in Iranian patients: a preliminary study.
    Archives of Iranian medicine, 2006, Volume: 9, Issue:4

    Topics: ABO Blood-Group System; Adolescent; Adult; Antibodies, Monoclonal; Antineoplastic Agents; Bone Marrow Transplantation; Child; Erythrocytes; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Iran; Male; Vidarabine

2006
Lymphocytes with a CD4+ CD8- CD3- phenotype are effectors of experimental cutaneous graft-versus-host disease.
    Proceedings of the National Academy of Sciences of the United States of America, 1991, Dec-01, Volume: 88, Issue:23

    Topics: Animals; Antigens, Differentiation, T-Lymphocyte; Bone Marrow Transplantation; CD3 Complex; CD4 Antigens; CD8 Antigens; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique; Graft vs Host Disease; Lymphocyte Depletion; Mice; Mice, Inbred CBA; Phenotype; Receptors, Antigen, T-Cell; Skin Diseases; Spleen; T-Lymphocyte Subsets; T-Lymphocytes

1991